Patrick K. Noonan

1.3k total citations
40 papers, 901 citations indexed

About

Patrick K. Noonan is a scholar working on Pharmaceutical Science, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Patrick K. Noonan has authored 40 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 10 papers in Physiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Patrick K. Noonan's work include Advancements in Transdermal Drug Delivery (9 papers), Pain Mechanisms and Treatments (5 papers) and Dermatology and Skin Diseases (5 papers). Patrick K. Noonan is often cited by papers focused on Advancements in Transdermal Drug Delivery (9 papers), Pain Mechanisms and Treatments (5 papers) and Dermatology and Skin Diseases (5 papers). Patrick K. Noonan collaborates with scholars based in United States, France and Italy. Patrick K. Noonan's co-authors include Ronald C. Wester, Leslie Z. Benet, Howard I. Maïbach, Roger Williams, Mario Ángel-González, Keith Gottesdiener, Howard I. Maibach, Duane Burton, Andrea Shin and Adrian Vella and has published in prestigious journals such as Diabetes Care, Stroke and The American Journal of Cardiology.

In The Last Decade

Patrick K. Noonan

39 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick K. Noonan United States 20 280 184 179 105 94 40 901
Promila Pandhi India 23 54 0.2× 220 1.2× 51 0.3× 147 1.4× 46 0.5× 55 1.3k
Ritschel Wa United States 15 263 0.9× 38 0.2× 30 0.2× 87 0.8× 24 0.3× 80 775
DG Waller United Kingdom 17 61 0.2× 64 0.3× 24 0.1× 137 1.3× 40 0.4× 28 920
J. Nimmo United Kingdom 11 102 0.4× 131 0.7× 14 0.1× 129 1.2× 188 2.0× 16 916
A. Gérardin Switzerland 13 107 0.4× 87 0.5× 21 0.1× 153 1.5× 7 0.1× 25 630
Roger K. Ferguson United States 22 65 0.2× 90 0.5× 15 0.1× 128 1.2× 61 0.6× 71 1.2k
Xue Chen China 16 29 0.1× 488 2.7× 34 0.2× 107 1.0× 35 0.4× 47 2.0k
D Hartmann Switzerland 20 28 0.1× 198 1.1× 30 0.2× 353 3.4× 19 0.2× 65 1.5k
Christian de Mey Germany 22 41 0.1× 219 1.2× 13 0.1× 112 1.1× 63 0.7× 104 1.3k
D. Tang–Liu United States 12 47 0.2× 24 0.1× 36 0.2× 182 1.7× 35 0.4× 22 701

Countries citing papers authored by Patrick K. Noonan

Since Specialization
Citations

This map shows the geographic impact of Patrick K. Noonan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick K. Noonan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick K. Noonan more than expected).

Fields of papers citing papers by Patrick K. Noonan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick K. Noonan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick K. Noonan. The network helps show where Patrick K. Noonan may publish in the future.

Co-authorship network of co-authors of Patrick K. Noonan

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick K. Noonan. A scholar is included among the top collaborators of Patrick K. Noonan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick K. Noonan. Patrick K. Noonan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spencer, Robert H., Patrick K. Noonan, Thomas Marbury, & Frédérique Menzaghi. (2024). Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus. BMC Nephrology. 25(1). 351–351. 2 indexed citations
2.
Stark, Jeffrey G., et al.. (2023). Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis. Clinical Pharmacokinetics. 62(9). 1231–1241. 7 indexed citations
3.
Coombs, Laura P., Jana G. Delfino, Amir Khan, et al.. (2023). Real-World Performance of Large Vessel Occlusion Artificial Intelligence–Based Computer-Aided Triage and Notification Algorithms—What the Stroke Team Needs to Know. Journal of the American College of Radiology. 21(2). 329–340. 12 indexed citations
4.
Greene, Spencer, Patrick K. Noonan, Carlos Sanabria, & W. Frank Peacock. (2016). Effervescent N-Acetylcysteine Tablets versus Oral Solution N-Acetylcysteine in Fasting Healthy Adults: An Open-Label, Randomized, Single-Dose, Crossover, Relative Bioavailability Study. Current Therapeutic Research. 83. 1–7. 18 indexed citations
5.
Kopecky, Ernest A., et al.. (2014). Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: An extended-release, abuse-deterrent formulation. Journal of Opioid Management. 10(4). 233–246. 29 indexed citations
6.
Ploeg, Lex Van der, Shubh D. Sharma, Rakesh Datta, et al.. (2014). Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131. Life Sciences. 109(1). 20–29. 43 indexed citations
7.
Noonan, Patrick K., et al.. (2012). Steady State Plasma Levels of Bupropion After Administration of 3x150 Mg Extended Release Reference Tablets and Switching to 1x450 Mg Extended Release 450ER Tablets. Zenodo (CERN European Organization for Nuclear Research). 26–31. 2 indexed citations
8.
Basu, Prabir K., Bing Cai, Gary W. Cleary, et al.. (2012). Passive Transdermal Systems Whitepaper Incorporating Current Chemistry, Manufacturing and Controls (CMC) Development Principles. AAPS PharmSciTech. 13(1). 218–230. 27 indexed citations
9.
Shin, Andrea, Michael Camilleri, Irene Busciglio, et al.. (2012). Randomized Controlled Phase Ib Study of Ghrelin Agonist, RM-131, in Type 2 Diabetic Women With Delayed Gastric Emptying. Diabetes Care. 36(1). 41–48. 85 indexed citations
10.
Block, Lawrence H., et al.. (1993). The Impact of Lag Time on the Estimation of Pharmacokinetic Parameters. I. One-Compartment Open Model. Pharmaceutical Research. 10(7). 1031–1036. 27 indexed citations
11.
Teresi, M., Charles E. Riggs, Philippa Webster, et al.. (1993). Bioequivalence of Two Methotrexate Formulations in Psoriatic and Cancer Patients. Annals of Pharmacotherapy. 27(12). 1434–1438. 2 indexed citations
12.
Jewell, Roxanne C., et al.. (1992). Dose Proportionality of Transdermal Nitroglycerin. Pharmaceutical Research. 9(10). 1284–1289. 2 indexed citations
13.
Noonan, Patrick K., et al.. (1989). Gas chromatographic determination of gallopamil and norgallopamil in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 487(1). 73–80. 3 indexed citations
14.
Noonan, Patrick K. & Mario Ángel-González. (1989). Pharmacokinetics and the Variability of Percutaneous Absorption. Journal of Toxicology Cutaneous and Ocular Toxicology. 8(4). 511–516. 8 indexed citations
15.
16.
Nakashima, Emi, Patrick K. Noonan, & Leslie Z. Benet. (1987). Transdermal bioavailability and first-pass skin metabolism: A preliminary evaluation with nitroglycerin. Journal of Pharmacokinetics and Biopharmaceutics. 15(4). 423–437. 22 indexed citations
17.
Noonan, Patrick K., et al.. (1986). Relative Bioavailability of a New Transdermal Nitroglycerin Delivery System. Journal of Pharmaceutical Sciences. 75(7). 688–691. 32 indexed citations
18.
Noonan, Patrick K., et al.. (1983). Pharmacokinetics and Bioavailability of Intravenous and Topical Nitroglycerin in the Rhesus Monkey: Estimate of Percutaneous First-Pass Metabolism. Journal of Pharmaceutical Sciences. 72(7). 745–748. 43 indexed citations
19.
Wester, Ronald C. & Patrick K. Noonan. (1980). Relevance of animal models for percutaneous absorption. International Journal of Pharmaceutics. 7(2). 99–110. 88 indexed citations
20.
Wester, Ronald C. & Patrick K. Noonan. (1978). Topical Bioavailability of A Potential Anti-Acne Agent (SC-23110) as Determined by Cumulative Excretion and Areas Under Plasma Concentration Time Curves. Journal of Investigative Dermatology. 70(2). 92–94. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Promila Pandhi Breakdown of academic impact, for papers by Ritschel Wa Breakdown of academic impact, for papers by DG Waller Breakdown of academic impact, for papers by J. Nimmo Breakdown of academic impact, for papers by A. Gérardin Breakdown of academic impact, for papers by Roger K. Ferguson Breakdown of academic impact, for papers by Xue Chen Breakdown of academic impact, for papers by D Hartmann Breakdown of academic impact, for papers by Christian de Mey Breakdown of academic impact, for papers by D. Tang–Liu
Rankless by CCL
2026